Philogen S.p. A announced a EUR 62 million financing round from current and new private investors. The company also announced the appointment of three new board members, Dr. Guido Guidi previously Head of Oncology Europe at Novartis, Dr. Roberto Marsella previously Director of Investments of Fondo Strategico Italiano /CDP Equity, now with Generali, and Dr. Roberto Ferraresi previously partner of PAI partners and currently CEO of The Equity Club.